Elite Pharma Performance
| ELTPDelisted Stock | USD 0.04 0 6.75% |
The firm shows a Beta (market volatility) of -1.91, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Elite Pharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Elite Pharma is expected to outperform it. Elite Pharma right now shows a risk of 0.0%. Please confirm Elite Pharma maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Elite Pharma will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Elite Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Elite Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 3.6 M | |
| Total Cashflows From Investing Activities | -498.6 K |
Elite |
Elite Pharma Relative Risk vs. Return Landscape
If you would invest 3.73 in Elite Pharma on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Elite Pharma or generate 0.0% return on investment over 90 days. Elite Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Elite, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Elite Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elite Pharma's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Elite Pharma, and traders can use it to determine the average amount a Elite Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ELTP |
Based on monthly moving average Elite Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elite Pharma by adding Elite Pharma to a well-diversified portfolio.
Elite Pharma Fundamentals Growth
Elite OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Elite Pharma, and Elite Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elite OTC Stock performance.
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0739 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 27.92 M | ||||
| Shares Outstanding | 1.01 B | ||||
| Price To Earning | 5.21 X | ||||
| Price To Book | 1.12 X | ||||
| Price To Sales | 0.92 X | ||||
| Revenue | 32.26 M | ||||
| EBITDA | 7.93 M | ||||
| Cash And Equivalents | 19.78 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 1.39 M | ||||
| Debt To Equity | 0.57 % | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | 6.51 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Total Asset | 35.15 M | ||||
| Retained Earnings | (147.41 M) | ||||
| Current Asset | 19.66 M | ||||
| Current Liabilities | 5.13 M | ||||
About Elite Pharma Performance
Assessing Elite Pharma's fundamental ratios provides investors with valuable insights into Elite Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Elite Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.Things to note about Elite Pharma performance evaluation
Checking the ongoing alerts about Elite Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Elite Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elite Pharma is not yet fully synchronised with the market data | |
| Elite Pharma has some characteristics of a very speculative penny stock | |
| Elite Pharma has a very high chance of going through financial distress in the upcoming years | |
| About 18.0% of the company shares are held by company insiders |
- Analyzing Elite Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elite Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Elite Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elite Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elite Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Elite Pharma's otc stock. These opinions can provide insight into Elite Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |